2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Infectious: new trials by email Literature Review of Infectious trials Research Report on Infectious
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| China Registration Study in Patients With Skin Infections Daptomycin, Vancomycin - Skin Diseases, Infectious | Phase 3 | Completed | AstraZeneca | 265 | 2008-09-01 | 2015-03-09 |
| GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. darunavir, ritonavir - HIV, Infectious | Phase 3 | Completed | Tibotec, Inc | 429 | 2006-11-01 | 2014-04-21 |
Communicable Diseases (2) · Acquired Immunodeficiency Syndrome (1) · Cellulitis (1) · Skin Diseases (1)
Disease Attributes (2) · Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Blood-Borne Infections (1) · Connective Tissue Diseases (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Inflammation (1) · Lentivirus Infections (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1)
Daptomycin (1) · Darunavir (1) · Ritonavir (1) · Vancomycin (1)
AstraZeneca (1) · Tibotec, Inc (1)
Canada (1) · China (1) · Puerto Rico (1) · United States (1)
Karen Atkin (1) · Zhang Yingyuan, Prof. (1)